We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Results 1 to 5 of 21
Most popular |Most recent

Federal Government Publishes Amendments Significantly Altering Canada’s Patented Medicines Pricing Regime

Canada - August 22 2019 On August 21, 2019, the Government of Canada published amendments to the Patented Medicines Regulations that set out the long-awaited framework...

Rebecca Crane, Edwin Mok, Fiona Legere.

Overhaul of Canadian Pharmaceutical Pricing Regulations: Amendments to be Published August 21, 2019

Canada - August 12 2019 On August 9, 2019, Health Canada issued a press release announcing that the highly-anticipated amendments to the Patented Medicines Regulations (the...

Rebecca Crane, Edwin Mok, Fiona Legere.

Federal Court Abolishes ‘Reasonably Diligent Search’ Test and Invalidates Claims 9-10 in Aux Sable Patent Action

Canada - May 13 2019 On Friday, May 10 the Federal Court publicly released its decision in the patent impeachment action Aux Sable Liquid Products LP et al. V. JL...

Timothy St. J. Ellam, Steven Tanner, Kendra Levasseur.

USMCA: Four Important Changes to Intellectual Property Rights

Canada - October 5 2018 Earlier this week, Canada, the United States and Mexico reached an agreement in principle on the successor to NAFTA, dubbed the United...

Bart Nowak, Steven Tanner.

Federal Court of Canada Rejects NIAs, and Strikes S. 8 Damages in LOSEC (omeprazole) Patent Infringement Damages Decision

Canada - September 21 2017 In AstraZeneca v Apotex, 2017 FC 726, the Federal Court issued its damages decision concerning Apotex’s infringement of a patent pertaining to...

David Tait, Steven Tanner.